|
GOVERNMENT OF INDIA
MINISTRY OF FINANCE
(DEPARTMENT OF REVENUE)
Notification No. 83 /2017-Customs
New Delhi, the 31st October, 2017
G.S.R. (E). - In exercise of the powers conferred by sub-section (1) of
section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, on
being satisfied that it is necessary in the public interest so to do, hereby
makes the following further amendments in the notification of the Government of
India, in the Ministry of Finance (Department of Revenue),
No. 16/2017-Customs,
dated the 20th April, 2017, published in the Gazette of India, Extraordinary,
Part II, Section 3, Sub-section (i), vide number G.S.R.394 (E), dated the 20th
April, 2017, namely: -
In the said notification, in the Table, after serial number 27 and the
entries relating thereto, the following serial numbers and entries shall be
added, namely: -
| (1) |
(2) |
(3) |
(4) |
| 28 |
Erlotinib (Tarceva) |
The Blue Tree |
Roche Products (India) Private Limited |
| 29 |
Trastuzumab (Herclon) |
The Blue Tree |
Roche Products (India) Private Limited |
| 30 |
Pertuzumab (Perjeta) |
The Blue Tree |
Roche Products (India) Private Limited |
| 31 |
Transtuzumab Emtansine (Kadcyla) |
The Blue Tree |
Roche Products (India) Private Limited |
| 32 |
Obinutuzumab (Gazyva) |
The Blue Tree |
Roche Products (India) Private Limited |
| 33 |
Bevacizumab (Avastin) |
The Blue Tree |
Roche Products (India) Private Limited |
| 34 |
Tocilizumab (Actemra) |
Tocilizumab (Actemra) |
Roche Products (India) Private Limited |
| 35 |
Mycophenolate Mofetil (CellCept) |
Aarambh |
Roche Products (India) Private Limited |
| 36 |
Avonex (Interferon Beta 1A) |
Reach |
UCB India Private Limited |
| 37 |
Tysabri (Monoclonal Antibody |
Reach |
UCB India Private Limited |
| 38 |
Tecfidera (Dimethyl Fumarate) |
Reach |
UCB India Private Limited |
| 39 |
Plegridy (Peggylated Interferon Beta 1A) |
Reach |
UCB India Private Limited |
| 40 |
Sorafenib (Nexavar) |
NexCSP (Nexavar Cancer Survivorship Program) |
Bayer Zydus Pharma Private Limited |
| 41 |
Sirturo (Bedaquiline) |
Bedaquiline Compassionate Use Program |
Janssen India, Johnson & Johnson Private Limited |
| 42 |
Darzalex (Daratumumab) |
Daratumumab Patient Assistance Program |
Janssen India, Johnson & Johnson Private Limited |
| 43 |
SUTENT |
- Patients initially pay for 12 strips (value equivalent of 50 mg)
and gets assistance of 12 strips free.
- Post purchase of 12
strips patients receive the drug free until prescribed by treating
physicians.
-Full subsidy for BPL patients |
Pfizer Products India Private Limited |
| 44 |
CRIZALK |
Patients will pay for 8 bottles (either 200 mg or 250 mg) and post
that will get the drug free until prescribed by treating physician. -
Full subsidy for BPL patients |
Pfizer Products India Private Limited |
| 45 |
INLYTA |
Sutent Patients who progresses and prescribed lnlyta as 2nd line
pays for 1 strip and gets 1 strip free.
- Patients who
progresses on other 1st line TKI pays for 2 strips and get 1 strip free.
-Ful1subsidy for BPL patients |
Pfizer Products India Private Limited |
| 46 |
PALBACE |
-Patients will pay for 10 cycles and post that will get free drug
support until prescribed by treating physicians.
- Full subsidy for
BPL patients |
Pfizer Products India Private Limited |
| 47 |
ENBREL |
ENLIVEN
-Enbrel 50 mg: 4+2PAP. Any further repeat purchase
will be given at a further discounted price
-Enbrel25mg: 8+4 PAP.
Any further repeat purchase will be given at a further discounted price
|
Pfizer Limited |
| 48 |
XELJANZ |
XELSOURCE
India specific price of Rs. 24000 per bottle (MRP is
Rs. 66000 per bottle) |
Pfizer Limited |
| 49 |
GENPTROPIN |
5+1 PAP |
Pfizer Products India Private Limited |
| 50 |
Atgam |
For AIIMS Delhi 5+1, KEM Mumbai 4+1, CMC Vellore 4+1 & Other
hospitals 20+4 |
Pfizer Products India Private Limited |
| 51 |
Aromasin |
PAP 1+1 |
Pfizer Products India Private Limited |
| 52 |
Campto |
PAP 1+1 |
Pfizer Products India Private Limited |
(Ruchi Bisht)
Under Secretary to the Government of India
[F. No.
332/24/2010-TRU (Pt. I)]
Note: The principal notification No. 16/2017-Customs, dated the 20th April,
2017, published in the Gazette of India, Extraordinary, Part II, Section 3,
Sub-section (i) vide number G.S.R.394 (E), dated the 20th April, 2017.
|